CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells. (Q48124547)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

CD20-Specific Immunoligands Engaging NKG2D Enhance γδ T Cell-Mediated Lysis of Lymphoma Cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Christian Kellner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

M Peipp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

D Wesch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

H-H Oberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

S Lutz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

A Muskulus

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

J G J van de Winkel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

R Burger

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

A Humpe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

D Kabelitz

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

M Gramatzki

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

1 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

196-206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.

25 March 2020

cites work

1 reference

Perspectives of gammadelta T cells in tumor immunology

21 January 2018

1 reference

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

21 January 2018

1 reference

Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells

21 January 2018

1 reference

RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor

21 January 2018

1 reference

Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity

21 January 2018

1 reference

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

Effect of NKG2D ligand expression on host immune responses

21 January 2018

1 reference

NKG2D ligands in tumor immunity

21 January 2018

1 reference

T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial gamma delta T cells

21 January 2018

1 reference

Crystal structure of a T-cell receptor specific for the human MHC class I homolog MICA

21 January 2018

1 reference

The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D.

21 January 2018

1 reference

Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.

21 January 2018

1 reference

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells

21 January 2018

1 reference

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

21 January 2018

1 reference

NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.

21 January 2018

1 reference

Activation of V gamma 9V delta 2 T cells by NKG2D.

21 January 2018

1 reference

Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptors

21 January 2018

1 reference

Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells

21 January 2018

1 reference

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo

21 January 2018

1 reference

Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

21 January 2018

1 reference

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells.

21 January 2018

1 reference

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

21 January 2018

1 reference

Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study.

21 January 2018

1 reference

Gammadelta T cells for immune therapy of patients with lymphoid malignancies

21 January 2018

1 reference

Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors

21 January 2018

1 reference

Natural killer and gammadelta T cells in haematological malignancies: enhancing the immune effectors

21 January 2018

1 reference

Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity

21 January 2018

1 reference

Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma

21 January 2018

1 reference

Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

21 January 2018

1 reference

Human kappa light chain targeted Pseudomonas exotoxin A--identifying human antibodies and Fab fragments with favorable characteristics for antibody-drug conjugate development

21 January 2018

1 reference

A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo

21 January 2018

1 reference

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity

21 January 2018

1 reference

Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30.

21 January 2018

1 reference

Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside

21 January 2018

1 reference

In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model

21 January 2018

1 reference

Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement

21 January 2018

1 reference

Isopentenyl pyrophosphate-activated CD56+ {gamma}{delta} T lymphocytes display potent antitumor activity toward human squamous cell carcinoma

21 January 2018

1 reference

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

21 January 2018

1 reference

Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity

21 January 2018

1 reference

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/SJI.12581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28708284%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference